Linkedin
Sign in
Thought Leadership
Healthcare C-Suite Movements
Digital in Pharma
Events
FFE+CEO RT
BrandStorm
Solutions & Pricing
Partner
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Type here...
Search
Home
About
Editor’s Corner
Contribute
Contact Us
Thought Leadership
Healthcare C-Suite Movements
Digital in Pharma
Events
Solutions & Pricing
Partner
Instagram
Linkedin
Twitter
Subscribe
Subscribe
Tuesday, April 28, 2026
34.6
C
Bengaluru
Home
About
Editor’s Corner
Contribute
Contact Us
My account
Get into your account.
Login
Register
type here...
Search
Facebook
Linkedin
Twitter
Youtube
Thought Leadership
Healthcare C-Suite Movements
Digital in Pharma
Events
FFE+CEO RT
BrandStorm
Solutions & Pricing
Partner
Hot topics
Glosing the Gender Gap
0
Guest Editorial by Sharadha Iyer on the urgent need to close the gender gap in the Indian Pharma Industry
Mounjaro to Orforglipro: Lilly’s $6 Billion Bet on the Next GLP‑1 Revolution
0
Eli Lilly is in a rare position. Its GLP-1...
Blinkit, Zepto, Instamart: Who Will Own India’s At‑Home Diagnostics Market?
0
India’s diagnostics market is undergoing a quiet but profound...
Culture and Resistance to Change – A Pharma SFE Adoption Case Study
0
As an MNC Head, I was one among the...
Philippe Gautron Takes on Role as Senior Vice President & Business Head – APAC at Glenmark Pharmaceuticals
0
Ho Chi Minh City, Vietnam, March 2026 — Glenmark...
Facebook
Linkedin
Twitter
Youtube
Healthcare Trends
Tez Health and the New Race to Bring Healthcare Home
0
Tez Health and the New Race to Bring Healthcare...
Is Pharma M&A Slowing Down Amidst Geopolitical Friction?
0
The pharmaceutical industry stands at a critical juncture in...
Will the GLP Battle Now Shift from Injectable to Oral?
0
In India’s million-strong retail pharmacy universe, oral weight-loss pills...
The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap
0
The Semaglutide Shift: From Blockbuster to Commodity Why the $50...
Cytotoxics to Cell Therapy: A 40-Year Review of Indian Oncology Strategy
0
In 1989, oncology in India was not a business...
Marketing
Tez Health and the New Race to Bring Healthcare Home
0
Tez Health and the New Race to Bring Healthcare...
Is Pharma M&A Slowing Down Amidst Geopolitical Friction?
0
The pharmaceutical industry stands at a critical juncture in...
Will the GLP Battle Now Shift from Injectable to Oral?
0
In India’s million-strong retail pharmacy universe, oral weight-loss pills...
The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap
0
The Semaglutide Shift: From Blockbuster to Commodity Why the $50...
Cytotoxics to Cell Therapy: A 40-Year Review of Indian Oncology Strategy
0
In 1989, oncology in India was not a business...
Policies/Sales
Tez Health and the New Race to Bring Healthcare Home
0
Tez Health and the New Race to Bring Healthcare...
Is Pharma M&A Slowing Down Amidst Geopolitical Friction?
0
The pharmaceutical industry stands at a critical juncture in...
Will the GLP Battle Now Shift from Injectable to Oral?
0
In India’s million-strong retail pharmacy universe, oral weight-loss pills...
The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap
0
The Semaglutide Shift: From Blockbuster to Commodity Why the $50...
Cytotoxics to Cell Therapy: A 40-Year Review of Indian Oncology Strategy
0
In 1989, oncology in India was not a business...
Strategy
Tez Health and the New Race to Bring Healthcare Home
0
Tez Health and the New Race to Bring Healthcare...
Is Pharma M&A Slowing Down Amidst Geopolitical Friction?
0
The pharmaceutical industry stands at a critical juncture in...
Will the GLP Battle Now Shift from Injectable to Oral?
0
In India’s million-strong retail pharmacy universe, oral weight-loss pills...
The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap
0
The Semaglutide Shift: From Blockbuster to Commodity Why the $50...
Cytotoxics to Cell Therapy: A 40-Year Review of Indian Oncology Strategy
0
In 1989, oncology in India was not a business...
Subscribe
Thought Leadership
Healthcare C-Suite Movements
Digital in Pharma
Events
FFE+CEO RT
BrandStorm
Solutions & Pricing
Partner
Hot topics
Sales View – On-the-Go Information, Insights & Learning for Pharma Professionals
0
Sudarshan Jain, Secretary General of Indian Pharmaceutical Alliance (IPA)...
City Lungs Under Siege: Pigeon Droppings and Interstitial Lung Disease
0
Feeding pigeons may feel harmless — but for many...
Executive Compensation in Pharma Companies in India: MNCs vs Indian Firms
0
The pharmaceutical industry in India is a rapidly evolving...
How to Influence Patients to Adopt Healthy Lifestyle or Improve Adherence?
0
One of the many ways of influencing patients to...
A Tale of Two Companies – Sun Pharma’s Odyssey and Organon’s Second Act
0
Sun Pharma’s Odyssey and Organon’s Second Act – And...
Facebook
Linkedin
Twitter
Youtube
Healthcare Trends
Tez Health and the New Race to Bring Healthcare Home
0
Tez Health and the New Race to Bring Healthcare...
Is Pharma M&A Slowing Down Amidst Geopolitical Friction?
0
The pharmaceutical industry stands at a critical juncture in...
Will the GLP Battle Now Shift from Injectable to Oral?
0
In India’s million-strong retail pharmacy universe, oral weight-loss pills...
The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap
0
The Semaglutide Shift: From Blockbuster to Commodity Why the $50...
Cytotoxics to Cell Therapy: A 40-Year Review of Indian Oncology Strategy
0
In 1989, oncology in India was not a business...
Marketing
Tez Health and the New Race to Bring Healthcare Home
0
Tez Health and the New Race to Bring Healthcare...
Is Pharma M&A Slowing Down Amidst Geopolitical Friction?
0
The pharmaceutical industry stands at a critical juncture in...
Will the GLP Battle Now Shift from Injectable to Oral?
0
In India’s million-strong retail pharmacy universe, oral weight-loss pills...
The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap
0
The Semaglutide Shift: From Blockbuster to Commodity Why the $50...
Cytotoxics to Cell Therapy: A 40-Year Review of Indian Oncology Strategy
0
In 1989, oncology in India was not a business...
Policies/Sales
Tez Health and the New Race to Bring Healthcare Home
0
Tez Health and the New Race to Bring Healthcare...
Is Pharma M&A Slowing Down Amidst Geopolitical Friction?
0
The pharmaceutical industry stands at a critical juncture in...
Will the GLP Battle Now Shift from Injectable to Oral?
0
In India’s million-strong retail pharmacy universe, oral weight-loss pills...
The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap
0
The Semaglutide Shift: From Blockbuster to Commodity Why the $50...
Cytotoxics to Cell Therapy: A 40-Year Review of Indian Oncology Strategy
0
In 1989, oncology in India was not a business...
Strategy
Tez Health and the New Race to Bring Healthcare Home
0
Tez Health and the New Race to Bring Healthcare...
Is Pharma M&A Slowing Down Amidst Geopolitical Friction?
0
The pharmaceutical industry stands at a critical juncture in...
Will the GLP Battle Now Shift from Injectable to Oral?
0
In India’s million-strong retail pharmacy universe, oral weight-loss pills...
The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap
0
The Semaglutide Shift: From Blockbuster to Commodity Why the $50...
Cytotoxics to Cell Therapy: A 40-Year Review of Indian Oncology Strategy
0
In 1989, oncology in India was not a business...
Subscribe
Screen Shot 2015-01-02 at 9.17.45 PM